Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe

BACKGROUND: Paediatric atopic dermatitis (AD) can be burdensome, affecting mental health and impairing quality of life for children and caregivers. Comprehensive guidelines exist for managing paediatric AD, but practical guidance on using systemic therapy is limited, particularly for new therapies i...

Descripción completa

Detalles Bibliográficos
Autores principales: de Graaf, M., Janmohamed, S.R., Schuttelaar, M.L.A., Agner, T., Alfonso, J.H., De Schepper, S., Deleuran, M., Despontin, K., Elenius, V., Ghislain, P.‐D., Huilaja, L., Johansson, E.K., Kvenshagen, B.K., Mandelin, J.M., Olset, H., Svensson, A., van Tuyll van Serooskerken, A.M., Thyssen, J.P., Vestergaard, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles and Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796032/
https://www.ncbi.nlm.nih.gov/pubmed/35793471
http://dx.doi.org/10.1111/jdv.18410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796032/
https://www.ncbi.nlm.nih.gov/pubmed/35793471
http://dx.doi.org/10.1111/jdv.18410

Ejemplares similares